| 产品描述: | Leramistat (HMC-C-01-A; MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism regulation. Leramistat also inhibits ATP production in Thp1 human monocytes (IC50: 0.63 μM). Leramistat inhibits atopic dermatitis and other skin diseases autoimmune diseases, inflammatory diseases, cancer; and also inhibits osteoclast mediated disease. |
| 体内研究: |
Leramistat 在大鼠肝细胞中的稳定性一般,半衰期为 7 min,在人肝细胞中的半衰期为 154 min。 |
| 保存条件: |
-80°C 6个月; -20°C 1个月,避光,氮气保存 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.47 ml |
12.348 ml |
24.697 ml |
| 5 mM |
0.494 ml |
2.47 ml |
4.939 ml |
| 10 mM |
0.247 ml |
1.235 ml |
2.47 ml |
| 50 mM |
0.049 ml |
0.247 ml |
0.494 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |